APA (7th ed.) Citation

B, S., R, S., G, R., R, E., V, S., Jr, D. E., . . . S, M. (2024). Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection. JCI insight, 9(15), . https://doi.org/10.1172/jci.insight.179317

Chicago Style (17th ed.) Citation

B, Singh, et al. "Indoleamine-2,3-dioxygenase Inhibition Improves Immunity and Is Safe for Concurrent Use with CART During Mtb/SIV Coinfection." JCI Insight 9, no. 15 (2024). https://doi.org/10.1172/jci.insight.179317.

MLA (9th ed.) Citation

B, Singh, et al. "Indoleamine-2,3-dioxygenase Inhibition Improves Immunity and Is Safe for Concurrent Use with CART During Mtb/SIV Coinfection." JCI Insight, vol. 9, no. 15, 2024, https://doi.org/10.1172/jci.insight.179317.